Consolidated Balance Sheets - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Current assets
Cash	$ 650	$ 11,885
Accounts receivable	5,379	8,224
Other receivable	205,357	0
Total current assets	211,386	20,109
Assets from discontinued operations	0	563
Total assets	211,386	20,672
Current liabilities
Accounts payable and accrued liabilities	177,421	157,287
Notes payables, related party	55,416	133,585
Notes payable	30,298	29,560
Liabilities from discontinued operations	0	764,782
Total current liabilities	263,135	1,085,214
Total liabilities	263,135	1,085,214
Stockholders' Deficiency
Common stock, $0.001 par value; 275,000,000 shares authorized; 26,810,479 outstanding at December 31, 2023 and 23,644,061 outstanding at December 31, 2022	26,810	23,644
Common stock subscribed	325,122	0
Additional paid in capital	7,065,388	6,944,569
Accumulated other comprehensive income	9,990	588,885
Accumulated deficit	(7,479,059)	(8,685,640)
Total stockholders' deficiency	(51,749)	(1,064,542)
Total liabilities and stockholders' deficiency	211,386	20,672
Series A Convertible Preferred Stock [Member]
Stockholders' Deficiency
Series A convertible preferred stock, $1.00 par value; 5,000,000 shares authorized; Nil issued and outstanding at December 31, 2023 and December 31, 2022	0	0
Series B Convertible Preferred Stock [Member]
Stockholders' Deficiency
Series A convertible preferred stock, $1.00 par value; 5,000,000 shares authorized; Nil issued and outstanding at December 31, 2023 and December 31, 2022	$ 0	$ 64,000